Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

15. Juli 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3043


	Artikel 1 - 20 / 60841

	Smoking-attributable gastrointestinal cancer burden in Brazil, Russia, India, China and South Africa (BRICS) and Associated Economies: A Global Burden of Disease study analysis 1990-2023. Tob Prev Cessat Jiang W, Wang Y, Cheng R. PMID: 42453357 [PubMed - in process]
	Thermoresponsive Injectable Self-Healing Hydrogel Loaded with Self-Regenerating Photothermal Agent for Synergistic Photothermal-Thermodynamic-Chemodynamic Therapy for Pancreatic Cancer. Polymers (Basel) Li J, Yuan W. PMID: 42452077 [PubMed]
	Can Complex 3D Models Effectively Replace 2D and Animal Models to Investigate the Microbe-Tumor-Immune Axis in Pancreatic Cancer Studies? Nutrients Ozeer FZ, Kester JC. PMID: 42451117 [PubMed - in process]
	Modern Approaches to Diagnosis and Evaluation of Survival Prognosis in Patients with Pancreatic Cancer. Int J Mol Sci Getsina M, Tsyba N, Chernevskaya E. PMID: 42450138 [PubMed - in process]
	Gd-EOB-DTPA-Enhanced MRI Combined with ALBI Score and AFP for Predicting Histologic Grade in Hepatocellular Carcinoma: A Multicentre Study from Vietnam. Diagnostics (Basel) Nguyen VH, Vu DL, Pham TA, Nguyen CL, Le VK, Nguyen NT, Vu LM, Nguyen HH. PMID: 42449800 [PubMed]
	Single-Cell and Spatial Transcriptomics Reframe the Immunosuppressive Microenvironment of Neuroendocrine Neoplasms. Cancers (Basel) Takahashi Y, Tsunekawa S. PMID: 42449718 [PubMed]
	Systemic Treatment Strategies Beyond Chemotherapy in Recurrent or Advanced Endometrial Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel) Madár I, Szabó A, Cavalcante BGN, Vleskó G, Hegyi P, Ács N, Kói T, Kálovics E, Szabó G. PMID: 42449635 [PubMed]
	The Relationship Between Neutrophil Extracellular Traps and CD8(+) T Lymphocytes in Cancer: A Comprehensive Review of Current Data. Cancers (Basel) McKee KE, Zhang H, Tsung A, Ruff SM. PMID: 42449604 [PubMed]
	Cancer Diagnoses and Deaths in Hungary, 2011-2023: Nationwide Trends Before, During, and After the COVID-19 Pandemic. Cancers (Basel) Kiss Z, Szabó TG, Maráz A, Rokszin G, Horváth Z, Nagy P, Abonyi-Tóth Z, Kovács V, Surján O, Barcza Z, Kenessey I, Wéber A, Wittmann I, Molnár GA, Neuhauser N, Darida M, Köveskúti I, Tamás RB, Bogos K, Moldvay J, Gálffy G, Tamási L, Müller V, Krasznai ZT, Pápai-Székely Z, Baltás E, Gyulai RP, Boér K, Holló P, Kocsis J, Máté S, Nikolényi A, Novák Z, Rubovszky G, Dank M, Vokó Z. PMID: 42449573 [PubMed]
	Neurokinin-1 receptor antagonism as a potential therapeutic strategy for cancer treatment; enhancing anti-tumor efficacy while mitigating treatment-related toxicities. NPJ Precis Oncol Maitra A, Muñoz M, Coveñas R, Hoang T, Italia Z, Robinson P. PMID: 42448885 [PubMed - as supplied by publisher]
	Quality of Life Endpoints in Advanced Gastrointestinal Cancer Trials: Systematic Review of Inclusion, Challenges, and Implications (2020-2024). Clin Oncol (R Coll Radiol) Kalantri S, Kelley B, Freeman JQ, Akhiwu TO, Redman R. PMID: 42447620 [PubMed - as supplied by publisher]
	Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study. Eur J Cancer Broekman THT, Mackay TM, de Vos-Geelen J, Cirkel GA, Graus MUJE, de Groot JB, Homs MYV, Luelmo SAC, Mekenkamp LJM, Streppel MM, Voermans RP, Wumkes ML, Besselink MG, van der Geest LG, Wilmink JW, Dutch Pancreatic Cancer Group. PMID: 42447514 [PubMed - as supplied by publisher]
	HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients. Technol Cancer Res Treat Wang X, Zhang Q, Xu Y, Miao W, Tao B, Jin C, Fu D. PMID: 42446070 [PubMed - indexed for MEDLINE]
	Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis. Transl Cancer Res Qian J, Gao S, Zhu Y, Wu J. PMID: 42445439 [PubMed]
	Leveraging the perioperative window in pancreatic cancer: lessons from the PROSPER trial. Gland Surg Bethel F, Corona A, Hosein P, Datta J. PMID: 42445089 [PubMed]
	Case Report: A four-stage diagnostic cascade: from coronary stents to pancreatic cancer in a patient with recurrent chest pain. Front Oncol Lin T, Huang Z, Huang X. PMID: 42444795 [PubMed]
	Management of cancer-associated thrombosis in patients with gastrointestinal cancers: lights and shadows. Cancer Treat Rev Gervaso L, Cioli E, Rosanu NM, Cella CA, Khorana AA, Fazio N. PMID: 42443040 [PubMed - as supplied by publisher]
	Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis. BJS Open van Bodegraven AJ, Marstaller-Walz KM, Padoan V, Heo D, Perri G, Burchell GL, Loos M, Michalski CW, Besselink MG, Cillo U, Rompen IF, Marchegiani G. PMID: 42441942 [PubMed - indexed for MEDLINE]
	Baseline and dynamic neutrophil-to-lymphocyte ratio predicts overall survival in unresectable pancreatic cancer following dose-escalated SBRT: a ten-year longitudinal study. Front Mol Biosci Di Y, Sun Z, Song Z, Meng L. PMID: 42440477 [PubMed]
	Perioperative immune checkpoint inhibitors with or without chemotherapy versus placebo with or without chemotherapy in elderly people with localised non-small cell lung cancer. Cochrane Database Syst Rev Plissonneau E, Marchal C, Malouf R, Calais F, Westeel V, Orillard E. PMID: 42440312 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 60841

Seite 1 von 3043



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung